ARTICLE | Clinical News
Introgen preclinical data
April 10, 2006 7:00 AM UTC
In a mouse model of human lung cancer, INGN-241 plus Avastin led to about 70% complete tumor regression, resulting in significantly improved survival vs. either agent alone or controls. Data were pre...